Drug induced catanionic vesicles assisted fabrication of hollow silica nano-spheres as the new age chemo-drug carrier
Source abstract
Abstract
Abstract Surfactant vesicles have elicited the attention because of their non-toxic nature, ease of preparation, low cost programmable drug delivery vehicle and soft templates for the organized nano-assemblies. To unleash their potential as the new age drug carrier, herein we have designed catanionic vesicles formed through synergistic interactions between the hydrotropic drug diclofenac sodium (DS) and cationic gemini surfactants (GS) with varying alkyl chain lengths i.e. hexamethylene 1,6-bis (tetradecyl dimethyl ammonium bromide); and hexamethylene 1,6-bis (hexadecyl dimethyl ammonium bromide). The prepared catanionic vesicles were then used as the soft templates to synthesize hollow silica nano spheres with 62 nm size and 0.86 cm3/g pore volume to accommodate the anti-cancer drug imatinib mesylate. Results of encapsulation and release demonstrate that the studied system could potentially serve as a stable nano-delivery system for delivering the hydrophobic drugs in the future.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Surfactants and Colloidal Systems · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (79)
Show source-provided references
1. Synergism between anionic double tail and zwitterionic single tail surfactants in the formation of mixed micelles and vesicles, and use of the micelle templates for the synthesis of nano-structured gold particles10.1016/j.colsurfa.2015.06.032 ↗
2. Ionic liquid-based catanionic coacervates: novel microreactors for membrane-free sequestration of dyes and curcumin10.1021/acsomega.8b02455 ↗
3. Sodium salicylate mediated ionic liquid based catanionic coacervates as membrane-free microreactors for the selective sequestration of dyes and curcumin10.1002/syst.201900029 ↗
4. Poly(vinyl alcohol) and functionalized ionic liquid-based smart hydrogels for doxorubicin release10.1021/acsabm.0c00393 ↗
5. Hydrogenated/fluorinated catanionic surfactants as potential templates for nanostructure design10.1021/la2019346 ↗
6. Nanoliposomes and their applications in food nanotechnology10.1080/08982100802465941 ↗
7. Liposomes
8. Application of liposomes in the textile industry10.1134/S1070363213010428 ↗
9. Temperature-induced vesicle to micelle transition in cationic/cationic mixed surfactant systems10.1039/C5SM01825K ↗
10. pH- and concentration-induced micelle-to-vesicle transitions in pyrrolidone-based Gemini surfactants10.1007/s00396-013-3145-0 ↗
11. Synergistic interaction between cholesterol and functionalized ionic liquid based surfactant leading to the morphological transition10.1002/slct.201702561 ↗
12. Micelle-vesicle transitions in catanionic mixtures of SDS/DTAB induced by salt, temperature, and selective solvents: a dissipative particle dynamics simulation study10.1007/s00396-014-3258-0 ↗
13. Physicochemistry of CTAB-SDS interacted catanionic micelle-vesicle forming system: an extended exploration10.1016/j.colsurfa.2018.05.099 ↗
14. Salt-induced microstructural transitions in aqueous dispersions of ionic-liquids-based surfactants
15. Surface-bound lipid vesicles encapsulating redox species for amperometric biosensing of pore-forming bacterial toxins10.1021/ja027897f ↗
16. Zana · 2004
17. Patial · 2016
18. Interaction between ionic liquids and gemini surfactant: a detailed investigation into the role of ionic liquids in modifying properties of aqueous gemini surfactant10.1007/s11743-015-1747-x ↗
19. Formation of hydrotropic drug/gemini surfactant based catanionic vesicles as efficient nano drug delivery vehicles10.1016/j.colcom.2020.100273 ↗
20. Inclusion of a photosensitizer in liposomes formed by DMPC/gemini surfactant: correlation between physicochemical and biological features of the complexes10.1021/jm050182d ↗
21. K. Kwetkat, M. Brock and H. Koch, US Pat., 6156721, (2000).
22. Topical non-invasive gene delivery using gemini nanoparticles in interferon-γ-deficient mice10.1016/j.ejpb.2007.01.002 ↗
23. A gemini amphiphilic phase transfer catalyst for dark singlet oxygenation10.1002/poc.1344 ↗
24. Thermodynamics of micelle formation of the counterion coupled gemini surfactant bis(4-(2-dodecyl)benzenesulfonate)-jeffamine salt and its dynamic adsorption on sandstone10.1021/jp806522h ↗
25. Polymerizable semi-fluorinated gemini surfactants designed for antimicrobial materials10.1016/j.jcis.2008.12.038 ↗
26. Drug-induced micelle-to-vesicle transition of a cationic gemini surfactant: potential applications in drug delivery10.1002/cphc.201701134 ↗
27. Aqueous surfactant two-phase systems in a mixture of cationic gemini and anionic surfactants10.1021/la801301v ↗
28. Selective accumulation of dyes and curcumin in a macroscopic complex coacervates composed of morpholinium based ester functionalized ionic liquid and sodium salicylate10.1016/j.molliq.2020.114140 ↗
29. Sugar-based gemini surfactants with pH-dependent aggregation behavior: vesicle-to-micelle transition, critical micelle concentration, and vesicle surface charge reversal10.1021/la0343270 ↗
30. Synthesis and surface properties of a pH-regulated and pH-reversible anionic gemini surfactant10.1021/la5016669 ↗
31. Fabrication of pH-responsive system based on cationic gemini surfactant/sodium octanedioate and its application on controlled release of paclitaxel10.1016/j.colsurfa.2017.11.051 ↗
32. Temperature-induced micelle transition of gemini surfactant in aqueous solution10.1016/j.susc.2007.03.005 ↗
33. Surface tension and aggregation properties of novel cationic gemini surfactants with diethylammonium headgroups and a diamido spacer10.1021/la3011212 ↗
34. Effect of hydrotropic salt on the assembly transitions and rheological responses of cationic gemini surfactant solutions10.1021/jp0766205 ↗
35. Effects of inorganic and organic salts on aggregation behavior of cationic gemini surfactants10.1021/jp106031d ↗
36. Rich aggregate morphologies induced by organic salts in aqueous solutions of a cationic gemini surfactant with a short spacer10.1016/j.jcis.2009.08.023 ↗
37. The cholesterol aided micelle to vesicle transition of a cationic gemini surfactant (14-4-14) in aqueous medium10.1039/C5RA26507J ↗
38. Ionic liquid mediated micelle to vesicle transition of a cationic gemini surfactant: a spectroscopic investigation10.1039/C7SM02241G ↗
39. Vesicles from pH-regulated reversible gemini amino-acid surfactants as nanocapsules for delivery10.1016/j.colsurfb.2016.06.054 ↗
40. Enhanced intercellular release of anticancer drug by using nano-sized catanionic vesicles of doxorubicin hydrochloride and gemini surfactants10.1016/j.molliq.2018.03.065 ↗
41. Gemini surfactants templated mesoporous silica microparticles: from solid to hollow mesoporous spheres10.1002/cjoc.201700277 ↗
42. Controllable synthesis of hollow mesoporous silica nanoparticles templated by kinetic self-assembly using a gemini surfactant10.1039/c3ra22805c ↗
43. Three-dimensional low symmetry mesoporous silica structures templated from tetra-headgroup rigid bolaform quaternary ammonium surfactant10.1021/ja0502324 ↗
44. Synthesis of ordered and disordered silicas with uniform pores on the border between micropore and mesopore regions using short double-chain surfactants10.1021/ja0038326 ↗
45. Synthesis and characterization of ordered mesoporous silica using rosin-based gemini surfactants10.1007/s10853-017-1709-y ↗
46. Vesicle-directed growth of silica10.1002/1521-4095(200009)12:17<1286::AID-ADMA1286>3.0.CO;2-7 ↗
47. Acoustic cavitation leading to the morphosynthesis of mesoporous silica vesicles10.1002/1521-4095(20021002)14:19<1414::AID-ADMA1414>3.0.CO;2-F ↗
48. Fluorinated-surfactant-templated synthesis of hollow silica particles with a single layer of mesopores in their shells10.1002/adma.200500344 ↗
49. Synthesis of hollow silica spheres with mesostructured shell using cationic−anionic-neutral block copolymer ternary surfactants10.1021/la052129y ↗
50. Periodic mesoporous organosilica hollow spheres with tunable wall thickness10.1021/ja0607537 ↗
51. Synthesis of monodispersed mesoporous silica spheres (MMSSs) with controlled particle size using gemini surfactant10.1016/j.micromeso.2009.08.024 ↗
52. Facile synthesis of hierarchically porous silica nanocapsules and nanospheres via vesicle templating10.1016/j.colsurfa.2013.02.014 ↗
53. Controllable synthesis of hollow mesoporous silica spheres and application as support of nano-gold10.1016/j.jssc.2014.03.003 ↗
54. Highly dispersed molybdenum incorporated hollow mesoporous silica spheres as an efficient catalyst on epoxidation of olefins
55. Synthesis of core-shell and hollow structured dual-mesoporous silica templated by alkoxysilyl-functionalized ionic liquids and CTAB10.1016/j.matlet.2017.09.067 ↗
56. Effect of imidazolium-based ionic liquids on the aggregation behavior of twin-tailed cationic gemini surfactant in aqueous solution10.1080/01932691.2016.1170610 ↗
57. More · 2021
58. A fluorescence probe study of gemini surfactants in aqueous solution: a comparison between n-2-n and n-6-n series of the alkanediyl-a,w-bis (dimethylalkylammonium bromides)10.26850/1678-4618eqj.v32.2.2007.p47-54 ↗
59. Functionalized surfactant based catanionic vesicles as the soft template for the synthesis of hollow silica nanospheres as new age drug carrier10.1016/j.surfin.2020.100596 ↗
60. Alkanediyl-α,ω-bis(dimethylalkylammonium bromide) Surfactants: II. Krafft Temperature and Melting Temperature10.1006/jcis.2002.8457 ↗
61. Thermo-switchable de novo ionogel as metal absorbing and curcumin loaded smart bandage material10.1016/j.molliq.2020.112922 ↗
62. Sodium bromide induced micelle to vesicle transitions of newly synthesized anionic surface active ionic liquids based on dodecylbenzenesulfonate10.1021/jp512805e ↗
63. Drug induced micelle-to-vesicle transition in aqueous solutions of cationic surfactants10.1039/C6RA25577A ↗
64. Composition and concentration gradient induced structural transition from micelles to vesicles in the mixed system of ionic liquid–diclofenac sodium10.1021/acs.langmuir.6b01175 ↗
65. Interaction of tetracaine hydrochloride with sodium deoxycholate in aqueous micellar phase and at the surface10.1016/j.colsurfa.2014.11.001 ↗
66. Formation of wormlike micelle in a mixed amino-acid based anionic surfactant and cationic surfactant systems10.1016/j.jcis.2007.02.050 ↗
67. Formation and properties of wormlike micelles in solutions of a cationic surfactant with a 2-hydroxypropoxy insertion group10.1039/c3sm51017d ↗
68. Wormlike micelles and gels reinforced by hydrogen bonding in aqueous cationic gemini surfactant systems10.1039/c0sm01071e ↗
69. Ionic-liquid-based surfactants with unsaturated head group: synthesis and micellar properties of 1-(n-alkyl)-3-vinylimidazolium bromides10.1007/s00396-015-3746-x ↗
70. Effect of surfactant micelle shape transition on the microemulsion viscosity and its application in enhanced oil recovery processes10.1016/j.molliq.2014.07.009 ↗
71. Influence of the hydrogen-bond interactions on the excited-state dynamics of a push–pull azobenzene dye: the case of methyl Orange10.1039/C7CP08390D ↗
72. Vesicles formed in aqueous mixtures of cholesterol and imidazolium surface active ionic liquid: a comparison with common cationic surfactant by water dynamics10.1021/jp501033n ↗
73. Nano-vehicles for drug delivery using low-cost cationic surfactants: a drug induced structural transitions
74. Hydrothermal light-weight calcium phosphate cements: use of polyacrylnitrile-shelled hollow microspheres10.1023/A:1018601623600 ↗
75. One-pot synthesis of hollow superparamagnetic CoPt nanospheres10.1021/ja054442s ↗
76. C12mimBr ionic liquid/SDS vesicle formation and use as template for the synthesis of hollow silica spheres10.1021/la101221z ↗
77. Shape-tunable hollow silica nanomaterials based on a soft-templating method and their application as a drug carrier10.1021/am507642t ↗
78. Hollow mesoporous silica spheres synthesized with cationic and anionic mixed surfactant as templates10.1016/j.matlet.2014.11.092 ↗
79. Successful progressive challenge after a cutaneous reaction to imatinib mesylate (Gleevec): a case report and review of the literature